|
|||||
|
|
Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1–3?1 |
|
| Authors: | J J Zwaginga K S Sakariassen M R King T G Diacovo E F Grabowski G Nash M Hoylaerts J W M Heemskerk |
| Affiliation: | Department of Experimental Immunohaematology, Sanquin Research, Amsterdam, The Netherlands. j.j.zwaginga@lumc.nl |
| Abstract: | |
| Keywords: | |